Categories: News

OM1 Expands Rheumatology Conditions With Specialized Data For Licensing And Advanced Analytics

BOSTON, April 30, 2019 /PRNewswire/ — OM1, a leading health outcomes, data and technology company today announced that its rheumatology registries, which track hundreds of thousands of patients longitudinally throughout the United States, are now available for direct licensing as well as studies and advanced analytics. The registries include:

  • Rheumatoid Arthritis
  • Systemic Lupus Erythematosus
  • Sjögrens
  • Giant Cell Arteritis
  • Systemic Scleroderma
  • Juvenile Idiopathic Arthritis
  • Ankylosing Spondylitis
  • Hidradenitis Suppurativa

The OM1 registries are continually enrolling and updating and include patient reported outcomes as well as linkage to other data sources. These specialized clinical databases are used for streamlining research, understanding treatments and improving patient outcomes for life sciences companies and providers.   

“Understanding these conditions at a deeper level is critical to every stakeholder.  We are proud to be advancing research and improving care through better, more complete and timely data,” said Dr. Richard Gliklich, CEO of OM1. “Enabling our customers to have direct access to research-grade data will help advance care even more rapidly.”  

The registry data is available for licensing and through OM1’s advanced data visualization and analytics tools. For more information, visit www.om1.com.

Contact
Renee Hurley
Head of Marketing, OM1
617-620-9571
rhurley@om1.com

About OM1

OM1 is a leading health outcomes and technology company leveraging big clinical data and AI to better understand, compare, and predict patient outcomes. OM1’s real world evidence platform, clinical registries and AI technologies enable clients to accelerate research, measure and benchmark health outcomes and to personalize patient care.

View original content to download multimedia:http://www.prnewswire.com/news-releases/om1-expands-rheumatology-conditions-with-specialized-data-for-licensing-and-advanced-analytics-300840558.html

SOURCE OM1

Staff

Recent Posts

Delivra Health Brands Announces Appointment of New Director

Vancouver, British Columbia--(Newsfile Corp. - January 30, 2026) - Delivra Health Brands Inc. (TSXV: DHB) (OTCQB:…

49 minutes ago

KITS Eyecare Announces Expanded 2026 Pangolin Smart Glasses Lineup and Launch of KITS App

After selling out all previous Pangolin versions, KITS will release three additional Pangolin 3 Video…

3 hours ago

DentScribe Introduces “Talk Like You Always Do” AI Voice Perio Charting: Perio Findings Convert to Treatments and Revenue

SUNNYVALE, Calif., Jan. 30, 2026 /PRNewswire/ -- Perio charting shouldn't feel like operating a voice command…

3 hours ago

World Gym Corporation Presents at 2026 ICR Conference

Company Management Explores Public Listing in the U.S. and Highlights Launch of New Biomarker Tech…

3 hours ago

remedi Expands Waste Tracking and Reporting to Support Hospital Sustainability and Procurement Teams

Enhanced visibility helps healthcare systems measure landfill diversion, compliance, and operational performanceSAN ANTONIO, Jan. 29,…

9 hours ago

School-Reported Reading Assessments Show Atypical Gains for Students With Dyslexia

NWEA MAP®, STAR®, aReading, AUTOreading, and WIST Results Reflect Gains in Reading and Language SkillsJACKSONVILLE,…

9 hours ago